Sign In
Buy PFE
$25.36
-0.200 (-0.783%)
At Close: Jun 03, 2026
3 Best Healthcare Stocks: Quant Strong Buys From Goldman's 'Alpha' List
04:05pm, Monday, 17'th Nov 2025
The healthcare sector's renewed momentum offers fertile ground for investors wanting to outperform by picking the best stocks from the broader indexes. Goldman Sachs identified 29 healthcare stocks in
2 Giant Healthcare Stocks to Buy Hand Over Fist in November
10:00am, Monday, 17'th Nov 2025
Consider buying Medtronic for its dividend and Pfizer for its turnaround potential if you are looking for attractive healthcare investments in November.
Down 55%, Should You Buy the Dip on Pfizer?
04:35am, Monday, 17'th Nov 2025
Pfizer is a $145 billion pharmaceutical industry giant with a long history of success behind it. Wall Street bid the stock up during the COVID-19 pandemic, but now investors have soured on the shares.
Campbell & CO Investment Adviser LLC Has $347,000 Stock Position in Pfizer Inc. $PFE
04:32am, Monday, 17'th Nov 2025
Campbell and CO Investment Adviser LLC cut its holdings in Pfizer Inc. (NYSE: PFE) by 75.2% during the undefined quarter, according to its most recent disclosure with the Securities and Exchange Commi
Is Pfizer Stock a Buy After This $10 Billion Acquisition?
05:45am, Saturday, 15'th Nov 2025
Pfizer is buying out Metsera for up to $10 billion after an acquisition battle with another pharma giant. Metsera's leading candidate could be an excellent way for Pfizer to enter the weight-loss drug
Activist Starboard sells Pfizer stake after pushing for changes
06:33pm, Friday, 14'th Nov 2025
Activist investor Starboard Value has liquidated its position in Pfizer , according to a regulatory filing on Friday, ending its push for changes aimed at boosting the drugmaker's share price.
Biopharma companies have confidence in their ability to do deals: BMO's Evan Seigerman
03:19pm, Friday, 14'th Nov 2025
Evan Seigerman, BMO Capital Markets head of health care research, joins 'Power Lunch' to discuss what's behind the recent move in health care stocks, the state of play with GLP-1s and much more.
Prem Watsa's Strategic Moves: BlackBerry Ltd Sees a -1.32% Portfolio Impact
07:01am, Friday, 14'th Nov 2025
Exploring the Latest 13F Filing and Investment Adjustments Prem Watsa (Trades, Portfolio) recently submitted the 13F filing for the third quarter of 2025, prov
Pfizer Cuts BioNTech Stake by More Than Half
06:41am, Friday, 14'th Nov 2025
Pfizer Inc. (PFE, Financials) has reduced its ownership in German partner BioNTech SE by 54.7%, according to a regulatory filing released Thursday. The transact
Arvest Bank Trust Division Has $1.38 Million Stake in Pfizer Inc. $PFE
04:45am, Friday, 14'th Nov 2025
Arvest Bank Trust Division reduced its position in Pfizer Inc. (NYSE: PFE) by 22.7% during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange C
Pfizer's ex-R&D chief Dolsten withdraws from Novo Nordisk board race
06:19pm, Thursday, 13'th Nov 2025
Mikael Dolsten, Pfizer's former research and development chief, has withdrawn his candidacy for Novo Nordisk's board, citing personal reasons, the Danish drugmaker said on Thursday.
Pfizer sheds BioNTech stake years after blockbuster COVID vaccine tie-up
05:20pm, Thursday, 13'th Nov 2025
Pfizer Inc said on Thursday said that it will sell 54.7% of its stake in German drugmaker BioNTech SE , over five years after both firms formed an alliance that yielded a vaccine to combat the deadly
Pfizer CEO: RFK Jr. "clearly" was not his HHS Secretary choice
02:16pm, Thursday, 13'th Nov 2025
Pfizer CEO Albert Bourla doesn't think RFK Jr.'s views on vaccines will have long-term risks: "Vaccines have saved the world and we will continue doing that." About Yahoo Finance: Yahoo Finance provid
Pfizer CEO: AI will help with medicine's next big breakthrough
01:07pm, Thursday, 13'th Nov 2025
Fresh off Pfizer's (PFE) $10 billion battle to acquire Metsera (MTSR), Pfizer chairman and CEO Albert Bourla tells Yahoo Finance Executive Editor Brian Sozzi that the future for the pharmaceutical gia
Pfizer Completes Acquisition of Metsera
11:26am, Thursday, 13'th Nov 2025
NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) today announced the successful completion of its acquisition of Metsera, Inc. (NASDAQ: MTSR), a clinical-stage biopharmaceutical company accelerating
